Apply for a Fully Funded PhD in Cancer Immunometabolism Germany at the University of Würzburg. Open to international students. Deadline 10 Feb 2026.
Scholarship Advertisement
The Max Planck Research Group for Systems Immunology, in collaboration with Julius-Maximilians-University of Würzburg, invites applications for a fully funded PhD position in Cancer Immunometabolism. This doctoral opportunity is offered within a DFG-funded Collaborative Research Center (CRC 338) and focuses on immune cell metabolism in cancer and chronic disease models.

This scholarship provides advanced training in state-of-the-art molecular, cellular, and computational immunology techniques in an internationally recognized research environment.
About the Scholarship
Scholarship Overview
This PhD scholarship offers comprehensive academic training combined with a competitive salary under the German public service pay scale.
- Country: Germany
- University: Julius-Maximilians-University of Würzburg
- Research Institute: Max Planck Research Group for Systems Immunology
- Student Status: Open to international and domestic students
- IELTS: Not required (English proficiency sufficient)
- Duration: 3 to 4 years (standard PhD duration in Germany)
- Funding Type: Fully funded (TV-L E13, 65% salary)
- Deadline: 10 February 2026
Applicants are strongly encouraged to apply early for competitive consideration.
Admission Announcement Date
Official Announcement Timeline
- Scholarship Announcement: January 2026
- Application Review: Ongoing until deadline
- PhD Start Date: As agreed with the supervisor
Program Offered
Available PhD Program
The following doctoral program is offered:
- PhD in Cancer Immunometabolism
The research focuses on:
- T cell metabolism and differentiation
- Immune exhaustion in cancer
- Functional genomics and metabolomics
- Preclinical cancer and viral infection models
Eligibility Criteria of Each Program
Eligibility Requirements for PhD in Cancer Immunometabolism
Applicants must meet the following criteria:
- Master’s degree in life sciences, biology, biochemistry, or equivalent
- Strong academic background in immunology and/or metabolism
- Experience in molecular and cellular biology techniques
- Practical knowledge of immune cell isolation and in vitro culture
- Proficiency in English (German language not required)
- High motivation and commitment to academic research
Desirable Research Experience
Candidates with the following experience will be preferred:
- CRISPR or CRISPRi genome editing techniques
- Mouse handling and conditional knockout models
- Flow cytometry and cell sorting
- LC-MS-based metabolomics
- Single-cell RNA sequencing analysis
- Bioinformatics or computational biology skills
How to Apply
Application Submission Method
Applications must be submitted via email directly to the project supervisor.
- Application Email:
martin.vaeth1@uni-wuerzburg.de - Submission Format:
Combine all required documents into a single PDF file and email them before the deadline.
All application materials must be combined into one single PDF file and sent before the deadline.
Application Procedure
Step-by-Step Application Process
- Prepare all required academic documents
- Write a clear and focused motivation letter
- Combine documents into one PDF file
- Send the application via email to the official contact address
- Submit before 10 February 2026
Incomplete applications may not be considered.
Required Documents
Documents Checklist
Applicants must include the following documents:
- Motivation letter (1 to 1.5 pages) describing research experience and goals
- Recent academic CV
- Contact details of referees (full address and email)
- Proof of Master’s degree or expected completion
Last Date to Apply
Application Deadline
- Final date for submission: 10 February 2026. Applications received after the deadline will not be reviewed.
Apply now for this fully funded PhD in Cancer Immunometabolism in Germany and advance your research career at a world-class university with strong financial support, cutting-edge facilities, and global academic exposure.